Jack W. Callicutt - 03 Nov 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Nov 2025, 16:06:19 UTC
Prior SEC filing
15 Sep 2025
Next SEC filing
07 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jack W. Callicutt

Key filing fact

Jack W. Callicutt filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 05 Nov 2025.

Key facts

  • This page summarizes Jack W. Callicutt's Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
  • 18 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 05 Nov 2025, 16:06.

Change

  • Previous filing in this sequence was filed on 15 Sep 2025.
  • Current net transaction value: -$144,468.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001266773 Primary reporting owner

CALLICUTT JACK W

Relationship
Chief Financial Officer
Address
C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS
Signature
Jack W. Callicutt
Signature date
05 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GALT transaction

Common Stock

Options Exercise

Transaction value
$2,574
Shares
+1,300
Change %
+17%
Price
$1.98
Shares after
8,914
Date
03 Nov 2025
Ownership
Direct
Footnotes
F1
GALT transaction

Common Stock

Sale

Transaction value
$7,813
Shares
-1,300
Change %
-15%
Price
$6.01
Shares after
7,614
Date
03 Nov 2025
Ownership
Direct
Footnotes
F1, F2
GALT transaction

Common Stock

Options Exercise

Transaction value
$1,399
Shares
+1,260
Change %
+17%
Price
$1.11
Shares after
8,874
Date
03 Nov 2025
Ownership
Direct
Footnotes
F1
GALT transaction

Common Stock

Sale

Transaction value
$7,573
Shares
-1,260
Change %
-14%
Price
$6.01
Shares after
7,614
Date
03 Nov 2025
Ownership
Direct
Footnotes
F1, F2
GALT transaction

Common Stock

Options Exercise

Transaction value
$2,150
Shares
+1,250
Change %
+16%
Price
$1.72
Shares after
8,864
Date
03 Nov 2025
Ownership
Direct
Footnotes
F1
GALT transaction

Commno stock

Sale

Transaction value
$7,512
Shares
-1,250
Change %
-14%
Price
$6.01
Shares after
7,614
Date
03 Nov 2025
Ownership
Direct
Footnotes
F1, F2
GALT transaction

Common stock

Options Exercise

Transaction value
$17,650
Shares
+8,914
Change %
+117%
Price
$1.98
Shares after
16,528
Date
04 Nov 2025
Ownership
Direct
Footnotes
F1
GALT transaction

Common stock

Sale

Transaction value
$54,108
Shares
-8,914
Change %
-54%
Price
$6.07
Shares after
7,614
Date
04 Nov 2025
Ownership
Direct
Footnotes
F1, F6
GALT transaction

Common stock

Options Exercise

Transaction value
$9,961
Shares
+8,974
Change %
+118%
Price
$1.11
Shares after
16,588
Date
04 Nov 2025
Ownership
Direct
Footnotes
F1
GALT transaction

Common stock

Sale

Transaction value
$54,472
Shares
-8,974
Change %
-54%
Price
$6.07
Shares after
7,614
Date
04 Nov 2025
Ownership
Direct
Footnotes
F1, F6
GALT transaction

Common stock

Options Exercise

Transaction value
$18,475
Shares
+10,741
Change %
+141%
Price
$1.72
Shares after
18,355
Date
04 Nov 2025
Ownership
Direct
Footnotes
F1
GALT transaction

Common stock

Sale

Transaction value
$65,198
Shares
-10,741
Change %
-59%
Price
$6.07
Shares after
7,614
Date
04 Nov 2025
Ownership
Direct
Footnotes
F1, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GALT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-1,300
Change %
-2.6%
Price
$0.000000
Shares after
48,700
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,300
Exercise price
$1.98
Footnotes
F1, F3
GALT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-1,260
Change %
-2.5%
Price
$0.000000
Shares after
48,740
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,260
Exercise price
$1.11
Footnotes
F1, F4
GALT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-1,250
Change %
-1.9%
Price
$0.000000
Shares after
63,750
Date
03 Nov 2025
Ownership
Direct
Underlying class
Comm stock
Underlying amount
1,250
Exercise price
$1.72
Footnotes
F1, F5
GALT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-8,914
Change %
-18%
Price
$0.000000
Shares after
39,786
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
8,914
Exercise price
$1.98
Footnotes
F1, F3
GALT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-8,974
Change %
-18%
Price
$0.000000
Shares after
39,766
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
8,974
Exercise price
$1.11
Footnotes
F1, F4
GALT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-10,741
Change %
-17%
Price
$0.000000
Shares after
53,009
Date
04 Nov 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
10,741
Exercise price
$1.72
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.

Footnote F2

The shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Footnote F3

The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023.

Footnote F4

The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024.

Footnote F5

The options vested as follows: 25% on each of June 30, 2024, December 31, 2024, and June 30, 2025, with 25% scheduled to vest on December 31, 2025.

Footnote F6

The shares were sold in multiple transactions at prices ranging from $6.00 to $6.25. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .